Larson Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$14.8K | – | 2452 |
|
|
2024
Q1 | $14.8K | Buy |
+1,000
| New | +$14.8K | ﹤0.01% | 954 |
|
|
2023
Q4 | – | Sell |
-1,200
| Closed | -$5.46K | – | 1857 |
|
|
2023
Q3 | $5.46K | Hold |
1,200
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q2 | $8.45K | Hold |
1,200
| – | – | ﹤0.01% | 983 |
|
|
2023
Q1 | $7.33K | Hold |
1,200
| – | – | ﹤0.01% | 1001 |
|
|
2022
Q4 | $7.67K | Hold |
1,200
| – | – | ﹤0.01% | 936 |
|
|
2022
Q3 | $11K | Hold |
1,200
| – | – | ﹤0.01% | 771 |
|
|
2022
Q2 | $13K | Hold |
1,200
| – | – | ﹤0.01% | 639 |
|
|
2022
Q1 | $20K | Buy |
+1,200
| New | +$20K | ﹤0.01% | 525 |
|
|
2021
Q4 | – | Sell |
-800
| Closed | -$20K | – | 1119 |
|
|
2021
Q3 | $20K | Hold |
800
| – | – | ﹤0.01% | 467 |
|
|
2021
Q2 | $21K | Hold |
800
| – | – | ﹤0.01% | 428 |
|
|
2021
Q1 | $25K | Hold |
800
| – | – | 0.01% | 370 |
|
|
2020
Q4 | $37K | Hold |
800
| – | – | 0.01% | 256 |
|
|
2020
Q3 | $26K | Buy |
+800
| New | +$26K | 0.01% | 278 |
|